Comparison of Erector Spinae Plane Block and Caudal Block for Postoperative Analgesia in Pediatri… (NCT07762339) | Clinical Trial Compass
RecruitingNot Applicable
Comparison of Erector Spinae Plane Block and Caudal Block for Postoperative Analgesia in Pediatric Patients Undergoing Orchiopexy: A Prospective Observational Study
Turkey (Türkiye)84 participantsStarted 2026-06-08
Plain-language summary
This study aims to compare the analgesic efficacy of ultrasound-guided erector spinae plane block and caudal block for postoperative pain management in pediatric patients undergoing orchiopexy. Postoperative pain scores, time to first rescue analgesic requirement, total analgesic consumption, and block-related adverse effects will be evaluated during the first 24 hours after surgery. The study will assess whether erector spinae plane block provides effective postoperative analgesia comparable to or superior to caudal block in pediatric orchiopexy.
Who can participate
Age range
1 Year – 7 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Children aged 1 to 7 years with ASA physical status I-II undergoing unilateral orchiopexy surgery.
Exclusion Criteria:
* ASA physical status ≥ III
* History of prematurity (gestational age \< 37 weeks) Known coagulation disorders or bleeding tendency
* Infection, inflammation, or skin lesion at the injection site
* Known neurological or neuromuscular diseases
* Presence of significant cardiac or pulmonary disease (e.g., congenital heart disease, active asthma)
* Hepatic or renal dysfunction
* Known allergy or hypersensitivity to local anesthetics (e.g., bupivacaine, lidocaine)
* Developmental delay or cognitive impairment that prevents accurate pain assessment
* Use of additional regional analgesia techniques (e.g., caudal block) during surgery
* Block failure or intraoperative complications requiring exclusion from protocol analysis
* Lack of parental consent for participation in the study
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Time To First Analgesic Requirement After Surgery
Timeframe: First 24 hours postoperatively
Trial details
NCT IDNCT07762339
SponsorProf. Dr. Cemil Tascıoglu Education and Research Hospital Organization